Apotheek Katleen Vantieghem: what changed
Apotheek Katleen Vantieghem
Largest movements
- Cash +€37,781
up €37,781 (+24.7%), from €153,205 to €190,985
mainly Net result for the year (+€35,330) and Other debts (+€25,779)
- Receivables within one year +€22,055
up €22,055 (+47.7%), from €46,215 to €68,270
of which Trade receivables: +€21,019
- Tangible fixed assets -€16,693
down €16,693 (-29.3%), from €57,045 to €40,352
of which Land and buildings: -€16,158
- Other debts +€25,779
up €25,779 (+23.5%), from €109,896 to €135,675
- Trade debts +€17,568
up €17,568 (+54.3%), from €32,352 to €49,920
- Reserves +€13,664
up €13,664 (+12.1%), from €112,854 to €126,518
- Accrued charges and deferred income -€5,472
down €5,472 (-44.3%), from €12,352 to €6,879
- Gross operating margin -€63,610
down €63,610 (-38.5%), from €165,177 to €101,567
- Staff costs -€15,604
down €15,604 (-41.7%), from €37,423 to €21,819
- Depreciation -€14,946
down €14,946 (-43.0%), from €34,769 to €19,823
- Financial charges -€12,451
down €12,451 (-49.8%), from €24,999 to €12,547
- Taxes -€6,106
down €6,106 (-32.5%), from €18,810 to €12,704
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €383,493 | €430,931 | +€47,438 | +12.4% |
| Fixed assets | 21/28 | €57,045 | €40,352 | -€16,693 | -29.3% |
| Tangible fixed assets | 22/27 | €57,045 | €40,352 | -€16,693 | -29.3% |
| Land and buildings | 22 | €45,502 | €29,344 | -€16,158 | -35.5% |
| Plant, machinery and equipment | 23 | €10,486 | €7,627 | -€2,859 | -27.3% |
| Furniture and vehicles | 24 | €1,058 | €3,382 | +€2,324 | +220% |
| Current assets | 29/58 | €326,448 | €390,579 | +€64,131 | +19.6% |
| Stocks and contracts in progress | 3 | €121,073 | €125,029 | +€3,956 | +3.3% |
| Stocks | 30/36 | €121,073 | €125,029 | +€3,956 | +3.3% |
| Amounts receivable within one year | 40/41 | €46,215 | €68,270 | +€22,055 | +47.7% |
| Trade receivables | 40 | €46,215 | €67,235 | +€21,019 | +45.5% |
| Other amounts receivable | 41 | - | €1,036 | +€1,036 | |
| Current investments | 50/53 | €5,000 | €5,000 | = | 0.0% |
| Cash at bank and in hand | 54/58 | €153,205 | €190,985 | +€37,781 | +24.7% |
| Deferred charges and accrued income | 490/1 | €954 | €1,294 | +€340 | +35.6% |
| Total equity and liabilities | 10/49 | €383,493 | €430,931 | +€47,438 | +12.4% |
| Equity | 10/15 | €172,854 | €186,518 | +€13,664 | +7.9% |
| Contributions | 10/11 | €60,000 | €60,000 | = | 0.0% |
| Reserves | 13 | €112,854 | €126,518 | +€13,664 | +12.1% |
| Distributable reserves | 133 | €112,854 | €126,518 | +€13,664 | +12.1% |
| Amounts payable | 17/49 | €210,639 | €244,414 | +€33,774 | +16.0% |
| Amounts payable after more than one year | 17 | €41,190 | €41,190 | = | 0.0% |
| Other amounts payable | 178/9 | €41,190 | €41,190 | = | 0.0% |
| Amounts payable within one year | 42/48 | €157,098 | €196,344 | +€39,247 | +25.0% |
| Trade debts | 44 | €32,352 | €49,920 | +€17,568 | +54.3% |
| Suppliers | 440/4 | €32,352 | €49,920 | +€17,568 | +54.3% |
| Taxes, remuneration and social security | 45 | €14,850 | €10,749 | -€4,101 | -27.6% |
| Taxes | 450/3 | €12,334 | €7,604 | -€4,730 | -38.3% |
| Remuneration and social security | 454/9 | €2,516 | €3,145 | +€630 | +25.0% |
| Other amounts payable | 47/48 | €109,896 | €135,675 | +€25,779 | +23.5% |
| Accrued charges and deferred income | 492/3 | €12,352 | €6,879 | -€5,472 | -44.3% |
| Remuneration, social security and pensions | 62 | €37,423 | €21,819 | -€15,604 | -41.7% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €34,769 | €19,823 | -€14,946 | -43.0% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | €1,123 | - | -€1,123 | |
| Other operating charges | 640/8 | €1,120 | €612 | -€508 | -45.4% |
| Gross operating margin | 9900 | €165,177 | €101,567 | -€63,610 | -38.5% |
| Operating profit (loss) | 9901 | €90,743 | €59,313 | -€31,430 | -34.6% |
| Financial income | 75/76B | €3,856 | €1,269 | -€2,588 | -67.1% |
| Recurring financial income | 75 | €3,856 | €1,269 | -€2,588 | -67.1% |
| Financial charges | 65/66B | €24,999 | €12,547 | -€12,451 | -49.8% |
| Recurring financial charges | 65 | €24,999 | €12,547 | -€12,451 | -49.8% |
| Profit (loss) for the period before taxes | 9903 | €69,600 | €48,034 | -€21,566 | -31.0% |
| Income taxes | 67/77 | €18,810 | €12,704 | -€6,106 | -32.5% |
| Profit (loss) for the period | 9904 | €50,790 | €35,330 | -€15,460 | -30.4% |
| Profit (loss) for the period to be appropriated | 9905 | €50,790 | €35,330 | -€15,460 | -30.4% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 2 November 2026 via checked.be.